156 related articles for article (PubMed ID: 15638037)
1. [Effect of the leukotriene receptor antagonist montelukast therapy on asthma in childhood].
Zsigmond G; Novák Z; Kósa L
Orv Hetil; 2004 Nov; 145(48):2431-5. PubMed ID: 15638037
[TBL] [Abstract][Full Text] [Related]
2. A subgroup analysis of the MONICA study: a 12-month, open-label study of add-on montelukast treatment in asthma patients.
Virchow JC; Mehta A; Ljungblad L; Mitfessel H
J Asthma; 2010 Nov; 47(9):986-93. PubMed ID: 20858152
[TBL] [Abstract][Full Text] [Related]
3. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
Wahn U; Dass SB
Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
[TBL] [Abstract][Full Text] [Related]
4. Montelukast in childhood asthma.
Mehta PN
Indian Pediatr; 2000 Nov; 37(11):1201-9. PubMed ID: 11086302
[No Abstract] [Full Text] [Related]
5. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
[TBL] [Abstract][Full Text] [Related]
6. Real-life effectiveness of Singulair (montelukast) in 506 children with mild to moderate asthma.
Amirav I
Isr Med Assoc J; 2008 Apr; 10(4):287-91. PubMed ID: 18548983
[TBL] [Abstract][Full Text] [Related]
7. [Importance of leukotriene antagonists in asthma therapy raised].
MMW Fortschr Med; 2008 Mar; 150(13):44-5. PubMed ID: 18522358
[No Abstract] [Full Text] [Related]
8. Leukotriene receptor antagonists: a good choice in the treatment of premenstrual asthma?
Pasaoglu G; Mungan D; Abadoglu O; Misirligil Z
J Asthma; 2008 Mar; 45(2):95-9. PubMed ID: 18350399
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
[TBL] [Abstract][Full Text] [Related]
10. Effects of montelukast on subjective and objective outcome measures in preschool asthmatic children.
Moeller A; Lehmann A; Knauer N; Albisetti M; Rochat M; Johannes W
Pediatr Pulmonol; 2008 Feb; 43(2):179-86. PubMed ID: 18085698
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy.
Johnston NW; Mandhane PJ; Dai J; Duncan JM; Greene JM; Lambert K; Sears MR
Pediatrics; 2007 Sep; 120(3):e702-12. PubMed ID: 17766511
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[TBL] [Abstract][Full Text] [Related]
13. Effects of antileukotriene among asthmatic patients.
Saenghirunvattana S
J Med Assoc Thai; 2001 May; 84(5):719-22. PubMed ID: 11560223
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
Virchow JC; Bachert C
Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
[TBL] [Abstract][Full Text] [Related]
15. Brief case series: montelukast, at doses recommended for asthma treatment, reduces disease severity and increases soluble CD14 in children with atopic dermatitis.
Hon KL; Leung TF; Ma KC; Wong Y; Fok TF
J Dermatolog Treat; 2005 Feb; 16(1):15-8. PubMed ID: 15897161
[TBL] [Abstract][Full Text] [Related]
16. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma.
Bisgaard H; Zielen S; Garcia-Garcia ML; Johnston SL; Gilles L; Menten J; Tozzi CA; Polos P
Am J Respir Crit Care Med; 2005 Feb; 171(4):315-22. PubMed ID: 15542792
[TBL] [Abstract][Full Text] [Related]
17. Extrapolating evidence beyond age groups.
Bisgaard H; Bønnelykke K
J Allergy Clin Immunol; 2008 Apr; 121(4):1066-7; author reply 1067-8. PubMed ID: 18325574
[No Abstract] [Full Text] [Related]
18. Effect of cysteinyl leukotriene receptor antagonist on CD11b and CD23 expression in asthmatic children.
Gagro A; Aberle N; Rabatić S; Ajduk J; Jelacić J; Dekaris D
Clin Exp Allergy; 2004 Jun; 34(6):939-44. PubMed ID: 15196283
[TBL] [Abstract][Full Text] [Related]
19. The anti-inflammatory effects of inhaled corticosteroids versus anti-leukotrienes on the lymphocyte P-glycoprotein (PGP) expression in asthmatic children.
Kopriva F; Dzubak P; Potesil J; Hajduch M
J Asthma; 2009 May; 46(4):366-70. PubMed ID: 19484671
[TBL] [Abstract][Full Text] [Related]
20. Montelukast in guidelines and beyond.
Bousquet J; Demoly P; Humbert M
Adv Ther; 2009 Jun; 26(6):575-87. PubMed ID: 19562275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
